Diantha Duvall, Chief Accounting Officer at Bioverativ Inc. (BIVV), sold 818 shares at $60.47 ($49K) on 2017-06-28, disclosed to the SEC on 2017-06-29.
Scheduled sale ($49k) by Chief Accounting Officer under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Nothing distinguishes this filing.
| Filing → |
| GNCA | SELL | 2022-04-05 | $1K | — | Filing → |
| GNCA | SELL | 2022-03-17 | $3K | — | Filing → |